Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services, LLC is recalling Amantadine HCL 100 mg tablets because they may have been mislabeled as other medications.
Aidapak Services, LLC is recalling 100 mcg cyanocobalamin tablets because they may have been mislabeled as guaiFENesin ER 600 mg tablets.
Aidapak Services, LLC is recalling Potassium Acid Phosphate tablets due to a potential label mixup with prednisone. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Vitamin B Complex capsules that may have been mislabeled as Acarbose tablets. The error involves a label mixup.
Aidapak Services, LLC is recalling Tolterodine Tartrate ER capsules because they may be mislabeled as Ranolazine ER or Ferrous Sulfate.
KVK-Tech, Inc. is recalling 104,551 bottles of Hydroxyzine Hydrochloride tablets because the active ingredient came from an unapproved source.
Aidapak Services, LLC is recalling Sotalol HCL 80 mg tablets because they may have been mislabeled as Diltiazem HCL or Propranolol HCL ER.
Aidapak Services is recalling 20 mg Pantoprazole Sodium DR tablets because they may be mislabeled as Hyoscyamine Sulfate or Multivitamin/Multimineral.
Bard Access Systems is recalling MRI Low Profile Single Lumen ports because some silicone catheters may be undersized to 5.3 Fr instead of the labeled 6.6 Fr.
Aidapak Services is recalling Raloxifene HCL tablets due to a potential label mixup with Isosorbide Mononitrate.
Aidapak Services is recalling Phenytoin Sodium ER capsules because they may have been mislabeled as Lithium Carbonate ER tablets.
Aidapak Services is recalling chlorpromazine HCl tablets that may be mislabeled as acyclovir or trimethobenzamide. The error occurred during repacking in four western states.
Aidapak Services is recalling Temazepam 7.5 mg capsules because they may be mislabeled as Calcium Citrate or Valsartan.
Aidapak Services, LLC is recalling 5 mg amlodipine besylate tablets that may have been mislabeled as cyanocobalamin. The error involves a label mixup affecting specific lots.
Aidapak Services is recalling Trifluoperazine HCL tablets because they may have been mislabeled as Terbutaline Sulfate.
Aidapak Services, LLC is recalling Niacin TR capsules because they may have been mislabeled as Methylergonovine Maleate tablets.
Aidapak Services, LLC is recalling Dicyclomine HCL 20 mg tablets because they may have been mislabeled as Ramipril 2.5 mg capsules.
Carl Zeiss Microscopy is recalling the Compensator Slider Lambda 6x20 component due to misalignment of the lambda plate.
Aidapak Services is recalling 500 mg sulfasalazine tablets that may be mislabeled as fluconazole or phenytoin sodium.
Aidapak Services, LLC is recalling Omega-3 Acid Ethyl Esters capsules due to a potential label mixup with other medications. The repacked drugs were distributed in four western states.
Novartis is recalling NeoCitran DM Cough & Cold powder packets because they may contain foreign substances. The products were distributed in the U.S., Canada, and other countries.
Aidapak Services, LLC is recalling Propafenone HCL 150 mg tablets because they may have been mislabeled as Fosinopril Sodium 10 mg tablets.
Aidapak Services, LLC is recalling Candesartan Cilexetil 16 mg tablets because they may have been mislabeled as Irbesartan 150 mg.
Aidapak Services, LLC is recalling 5 mg cyclobenzaprine tablets because they may have been mislabeled as ascorbic acid or atenolol.
Aidapak Services is recalling Levothyroxine Sodium tablets that may have been mislabeled as Pramipexole Di-HCl.